0000000001157913

AUTHOR

Iveta Bajare

showing 3 related works from this author

Decrease in annual incidence of acute coronary syndrome and restructuring of coronary care in Latvia

2014

Abstract Introduction Improvement in coronary heart disease prevention and treatment, as well as availability of coronary care facilities, is important for the reduction of acute coronary syndrome (ACS) incidence. Centralized acute coronary care system is crucial to provide optimal hospitalization and management algorithm for ACS patients. Aim The aim of the current report was to assess the annual incidence of ACS and the quality of acute coronary care in Latvia. Methods The Data from The Latvian Registry of Acute Coronary Syndromes were analyzed covering the time period from 2005 to 2010. Results Since the year 2005 the annual incidence of hospitalization due to ACS decreased significantly…

Emergency medical servicesmedicine.medical_specialtyAcute coronary syndromeInvasive strategybusiness.industryIncidence (epidemiology)medicine.medical_treatmentPrimary percutaneous coronary interventionPercutaneous coronary interventionmedicine.diseaseAnnual incidenceManagement algorithmEmergency medicinemedicineEmergency medical servicesRegistry dataAcute coronary syndromeIntensive care medicinebusinessCardiology and Cardiovascular MedicineCor et Vasa
researchProduct

A nationwide cross-sectional epidemiological study of cardiovascular risk factors as a tool for management of primary and secondary prevention in Lat…

2021

Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): EUROPEAN SOCIAL FUND MINISTRY OF HEALTH, LATVIA Background. An increasing prevalence (PREV.) of noncomunicable diseases is a major public health concern  in Latvia. Regular nationwide epidemiological studies present an opportunity to estimate the dinamics of PREV of health risk factors (RF) and thus assist in planning resources and improving prevention strategies at national level. Objective.  The aim  was to analyze the PREV of cardiovascular  RF identified in a  epidemiological study in 2019-2020. To assess changes in RF prevalence, the results were compared to data from a simi…

Secondary preventionmedicine.medical_specialtyPrimary (chemistry)Epidemiologybusiness.industryEnvironmental healthCardiovascular risk factorsEpidemiologyMedicineCardiology and Cardiovascular MedicinebusinessEuropean Journal of Preventive Cardiology
researchProduct

Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY regis…

2015

Background and objective: Management of outpatients with stable coronary artery disease (CAD) is important in secondary prevention. The objective was to describe differences in the characteristics of CAD patients in Latvia compared with other countries. Materials and methods: CLARIFY is an ongoing international, prospective, observational, longitudinal registry of outpatients with CAD. Data regarding treated outpatients with established CAD from the CLARIFY registry in Latvia (n = 120) were compared with those from the rest of Central-Eastern Europe (CEE) (n = 2888) and worldwide (n = 33,163). Results: Patients in Latvia had a larger waist circumference (101 [95–109] vs. 99 [91–106] in CEE,…

MaleMedicine (General)medicine.medical_specialtyWaistmedicine.medical_treatmentDiastoleCoronary artery disease; Latvia; Prevention; Risk factors; Medicine (all)Coronary artery diseaseBody Mass IndexNOCoronary artery diseaseR5-920Percutaneous Coronary InterventionGeneral & Internal MedicineInternal medicineSecondary PreventionmedicineHumansProspective StudiesRegistriesCoronary artery disease; Latvia; Risk factors; PreventionProspective cohort studyAgedMedicine(all)AspirinAspirinbusiness.industryPreventionMedicine (all)CLARIFY registry investigatorsPercutaneous coronary interventionMiddle Agedmedicine.diseaseLatviaBlood pressureRisk factorsEvidence-Based PracticeAutomotive EngineeringCardiologyFemaleWaist CircumferencebusinessBody mass indexmedicine.drugMedicina
researchProduct